UK markets open in 4 hours 20 minutes

Moderna, Inc. (0A45.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
167.05+1.85 (+1.12%)
At close: 06:35PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-17.73%
S&P500 52-week change 325.38%
52-week high 3217.15
52-week low 395.06
50-day moving average 3111.28
200-day moving average 3142.34

Share statistics

Avg vol (3-month) 312.06k
Avg vol (10-day) 317.17k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8346.02M
% held by insiders 19.60%
% held by institutions 173.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -115.82%
Operating margin (ttm)-758.08%

Management effectiveness

Return on assets (ttm)-15.72%
Return on equity (ttm)-37.68%

Income statement

Revenue (ttm)5.15B
Revenue per share (ttm)13.52
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)N/A
EBITDA -4.56B
Net income avi to common (ttm)-5.97B
Diluted EPS (ttm)34.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.52B
Total cash per share (mrq)22.24
Total debt (mrq)1.24B
Total debt/equity (mrq)9.65%
Current ratio (mrq)4.03
Book value per share (mrq)33.47

Cash flow statement

Operating cash flow (ttm)-2.88B
Levered free cash flow (ttm)-1.95B